These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 32063360)

  • 1. Hepatic CD147 knockout modulates liver steatosis and up-regulates autophagy in high-fat-diet-induced NAFLD mice.
    Lou J; Li C; Li ZS; Zhang T; Chen ZN; Bian H
    Biochem Biophys Res Commun; 2020 Apr; 524(4):1010-1017. PubMed ID: 32063360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
    Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
    EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation.
    Pan ZG; An XS
    Biochem Biophys Res Commun; 2018 Apr; 498(3):416-423. PubMed ID: 29454967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A11 Promotes Liver Steatosis via FOXO1-Mediated Autophagy and Lipogenesis.
    Zhang L; Zhang Z; Li C; Zhu T; Gao J; Zhou H; Zheng Y; Chang Q; Wang M; Wu J; Ran L; Wu Y; Miao H; Zou X; Liang B
    Cell Mol Gastroenterol Hepatol; 2021; 11(3):697-724. PubMed ID: 33075563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin deficiency rescues high-fat diet-induced hepatic injury, apoptosis and autophagy loss despite persistent steatosis.
    Guo R; Nair S; Zhang Y; Ren J
    Int J Obes (Lond); 2017 Sep; 41(9):1403-1412. PubMed ID: 28559541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice.
    Tanaka S; Hikita H; Tatsumi T; Sakamori R; Nozaki Y; Sakane S; Shiode Y; Nakabori T; Saito Y; Hiramatsu N; Tabata K; Kawabata T; Hamasaki M; Eguchi H; Nagano H; Yoshimori T; Takehara T
    Hepatology; 2016 Dec; 64(6):1994-2014. PubMed ID: 27637015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic autophagy fluctuates during the development of non-alcoholic fatty liver disease.
    Ding H; Ge G; Tseng Y; Ma Y; Zhang J; Liu J
    Ann Hepatol; 2020; 19(5):516-522. PubMed ID: 32553647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The upregulation of Annexin A2 by TLR4 pathway facilitates lipid accumulation and liver injury via blocking AMPK/mTOR-mediated autophagy flux during the development of non-alcoholic fatty liver disease.
    Wu H; Zhou M; Jin Q; Wang X; Xu Y; Li M; Chen S; Tang Q; Wang Q; Hu B; Wu H; Xiao M; Qu L; Zhang Q; Liu J
    Hepatol Int; 2024 Aug; 18(4):1144-1157. PubMed ID: 38184503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Vsig4 attenuates macrophage-mediated hepatic inflammation and fibrosis in high fat diet (HFD)-induced mice.
    Li Y; Sun JP; Wang J; Lu WH; Xie LY; Lv J; Li HX; Yang SF
    Biochem Biophys Res Commun; 2019 Aug; 516(3):858-865. PubMed ID: 31266632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.
    He Q; Sha S; Sun L; Zhang J; Dong M
    Biochem Biophys Res Commun; 2016 Aug; 476(4):196-203. PubMed ID: 27208776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans.
    Cruces-Sande M; Vila-Bedmar R; Arcones AC; González-Rodríguez Á; Rada P; Gutiérrez-de-Juan V; Vargas-Castrillón J; Iruzubieta P; Sánchez-González C; Formentini L; Crespo J; García-Monzón C; Martínez-Chantar ML; Valverde ÁM; Mayor F; Murga C
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3655-3667. PubMed ID: 30261289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conophylline inhibits high fat diet-induced non-alcoholic fatty liver disease in mice.
    Ohashi T; Nakade Y; Ibusuki M; Kitano R; Yamauchi T; Kimoto S; Inoue T; Kobayashi Y; Sumida Y; Ito K; Nakao H; Umezawa K; Yoneda M
    PLoS One; 2019; 14(1):e0210068. PubMed ID: 30689650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human germline hedgehog pathway mutations predispose to fatty liver.
    Guillen-Sacoto MJ; Martinez AF; Abe Y; Kruszka P; Weiss K; Everson JL; Bataller R; Kleiner DE; Ward JM; Sulik KK; Lipinski RJ; Solomon BD; Muenke M
    J Hepatol; 2017 Oct; 67(4):809-817. PubMed ID: 28645738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis.
    Bozic M; Guzmán C; Benet M; Sánchez-Campos S; García-Monzón C; Gari E; Gatius S; Valdivielso JM; Jover R
    J Hepatol; 2016 Oct; 65(4):748-757. PubMed ID: 27245430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RORα contributes to the maintenance of genome ploidy in the liver of mice with diet-induced nonalcoholic steatohepatitis.
    Kim JY; Yang IS; Kim HJ; Yoon JY; Han YH; Seong JK; Lee MO
    Am J Physiol Endocrinol Metab; 2022 Feb; 322(2):E118-E131. PubMed ID: 34894722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic STAMP2 alleviates high fat diet-induced hepatic steatosis and insulin resistance.
    Kim HY; Park SY; Lee MH; Rho JH; Oh YJ; Jung HU; Yoo SH; Jeong NY; Lee HJ; Suh S; Seo SY; Cheong J; Jeong JS; Yoo YH
    J Hepatol; 2015 Aug; 63(2):477-85. PubMed ID: 25646886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalpol induces autophagy and attenuates liver steatosis in ob/ob and high-fat diet-induced obese mice.
    Ren H; Wang D; Zhang L; Kang X; Li Y; Zhou X; Yuan G
    Aging (Albany NY); 2019 Nov; 11(21):9461-9477. PubMed ID: 31697646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
    Fu D; Cui H; Zhang Y
    Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD.
    Weber M; Mera P; Casas J; Salvador J; Rodríguez A; Alonso S; Sebastián D; Soler-Vázquez MC; Montironi C; Recalde S; Fucho R; Calderón-Domínguez M; Mir JF; Bartrons R; Escola-Gil JC; Sánchez-Infantes D; Zorzano A; Llorente-Cortes V; Casals N; Valentí V; Frühbeck G; Herrero L; Serra D
    FASEB J; 2020 Sep; 34(9):11816-11837. PubMed ID: 32666604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.